EDGAR Filing Documents for 0001493152-23-011771

Form 8-K - Current report:

SEC Accession No. 0001493152-23-011771

Filing Date

2023-04-10

Accepted

2023-04-10 17:26:12

Documents

Period of Report

2023-04-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	79396
2		ex10-1.htm	EX-10.1	328249
3		ex10-2.htm	EX-10.2	327038
4		ex10-3.htm	EX-10.3	199487
5		ex10-4.htm	EX-10.4	209248
	Complete submission text file	0001493152-23-011771.txt		1564949

Data Files

Seq	Description	Document	Type	Size
6	XBRL SCHEMA FILE	evfm-20230405.xsd	EX-101.SCH	3221
7	XBRL LABEL FILE	evfm-20230405_lab.xml	EX-101.LAB	34240
8	XBRL PRESENTATION FILE	evfm-20230405_pre.xml	EX-101.PRE	22355
10	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3512

Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130

Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900

Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)